DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dwqld9/pharmapoint) has announced the addition of the "PharmaPoint: Hemophilia A and B - Spain Drug Forecast and Market Analysis to 2022" report to their offering. The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is...
More...
